Cargando…
Use of lorlatinib subsequent to crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852628/ https://www.ncbi.nlm.nih.gov/pubmed/31807477 http://dx.doi.org/10.4103/sajc.sajc_169_19 |
| _version_ | 1783469881579012096 |
|---|---|
| author | Talreja, Vikas T. Noronha, Vanita Joshi, Amit Patil, Vijay Mahajan, Abhishek Prabhash, Kumar |
| author_facet | Talreja, Vikas T. Noronha, Vanita Joshi, Amit Patil, Vijay Mahajan, Abhishek Prabhash, Kumar |
| author_sort | Talreja, Vikas T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6852628 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68526282019-12-05 Use of lorlatinib subsequent to crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience Talreja, Vikas T. Noronha, Vanita Joshi, Amit Patil, Vijay Mahajan, Abhishek Prabhash, Kumar South Asian J Cancer Letter to the Editor Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6852628/ /pubmed/31807477 http://dx.doi.org/10.4103/sajc.sajc_169_19 Text en Copyright: © 2019 The South Asian Journal of Cancer http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Letter to the Editor Talreja, Vikas T. Noronha, Vanita Joshi, Amit Patil, Vijay Mahajan, Abhishek Prabhash, Kumar Use of lorlatinib subsequent to crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience |
| title | Use of lorlatinib subsequent to crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience |
| title_full | Use of lorlatinib subsequent to crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience |
| title_fullStr | Use of lorlatinib subsequent to crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience |
| title_full_unstemmed | Use of lorlatinib subsequent to crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience |
| title_short | Use of lorlatinib subsequent to crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience |
| title_sort | use of lorlatinib subsequent to crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: indian experience |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852628/ https://www.ncbi.nlm.nih.gov/pubmed/31807477 http://dx.doi.org/10.4103/sajc.sajc_169_19 |
| work_keys_str_mv | AT talrejavikast useoflorlatinibsubsequenttocrizotinibinanaplasticlymphomakinasepositivenonsmallcelllungcancerindianexperience AT noronhavanita useoflorlatinibsubsequenttocrizotinibinanaplasticlymphomakinasepositivenonsmallcelllungcancerindianexperience AT joshiamit useoflorlatinibsubsequenttocrizotinibinanaplasticlymphomakinasepositivenonsmallcelllungcancerindianexperience AT patilvijay useoflorlatinibsubsequenttocrizotinibinanaplasticlymphomakinasepositivenonsmallcelllungcancerindianexperience AT mahajanabhishek useoflorlatinibsubsequenttocrizotinibinanaplasticlymphomakinasepositivenonsmallcelllungcancerindianexperience AT prabhashkumar useoflorlatinibsubsequenttocrizotinibinanaplasticlymphomakinasepositivenonsmallcelllungcancerindianexperience |